Fortitude Advisory Group L.L.C. purchased a new position in Immutep Limited (NASDAQ:IMMP – Free Report) in the fourth quarter, Holdings Channel reports. The fund purchased 12,900 shares of the biotechnology company’s stock, valued at approximately $28,000.
Several other large investors also recently made changes to their positions in IMMP. XTX Topco Ltd acquired a new stake in Immutep in the 2nd quarter worth approximately $26,000. XY Capital Ltd lifted its stake in shares of Immutep by 108.3% in the third quarter. XY Capital Ltd now owns 108,349 shares of the biotechnology company’s stock worth $239,000 after buying an additional 56,344 shares during the last quarter. Finally, Meridian Wealth Management LLC boosted its holdings in shares of Immutep by 4.5% during the 3rd quarter. Meridian Wealth Management LLC now owns 398,450 shares of the biotechnology company’s stock worth $881,000 after buying an additional 17,250 shares during the period. Institutional investors own 2.32% of the company’s stock.
Analyst Ratings Changes
Separately, Robert W. Baird lifted their target price on shares of Immutep from $6.00 to $7.00 and gave the stock an “outperform” rating in a report on Friday, November 15th.
Immutep Stock Performance
Shares of IMMP opened at $1.94 on Tuesday. Immutep Limited has a 52 week low of $1.66 and a 52 week high of $3.34. The company has a 50-day simple moving average of $2.03 and a 200-day simple moving average of $2.10. The company has a quick ratio of 18.25, a current ratio of 18.25 and a debt-to-equity ratio of 0.01.
Immutep Company Profile
Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.
See Also
- Five stocks we like better than Immutep
- How to Find Undervalued Stocks
- Momentum Grows for These 3 Healthcare Stocks
- Best Aerospace Stocks Investing
- 3 Stocks Upgraded by Bank of America – Here’s Why They’re Bullish
- Retail Stocks Investing, Explained
- 2 Stocks to Benefit From China Tariff Resets: Is 60% a Bluff?
Want to see what other hedge funds are holding IMMP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Immutep Limited (NASDAQ:IMMP – Free Report).
Receive News & Ratings for Immutep Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immutep and related companies with MarketBeat.com's FREE daily email newsletter.